Inflammatory signaling through leukotriene receptors in atherosclerosis (Q37167787)

18 August 2017

1 reference

title

Inflammatory signaling through leukotriene receptors in atherosclerosis (English)

1 reference

18 August 2017

0 references

1 reference

Magnus Bäck

1

1 reference

18 August 2017

1 June 2008

1 reference

Current Atherosclerosis Reports

18 August 2017

1 reference

18 August 2017

10

1 reference

18 August 2017

3

1 reference

18 August 2017

244-251

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-008-0038-7

18 August 2017

0 references

cites work

Leukotriene biosynthesis by canine and human coronary arteries.

1 reference

12 December 2020

The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field

1 reference

12 December 2020

Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia

1 reference

12 December 2020

1 reference

12 December 2020

Leukotriene receptors: crucial components in vascular inflammation.

1 reference

12 December 2020

Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in mice

1 reference

12 December 2020

Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms

1 reference

12 December 2020

Inhibited aortic aneurysm formation in BLT1-deficient mice

1 reference

12 December 2020

Leukotriene B4 is an indirectly acting vasoconstrictor in guinea pig aorta via an inducible type of BLT receptor

1 reference

12 December 2020

Stimulation of matrix metalloproteinase‐dependent migration of T cells by eicosanoids

1 reference

12 December 2020

Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice

1 reference

12 December 2020

Cysteinyl leukotrienes enhance tumour necrosis factor-alpha-induced matrix metalloproteinase-9 in human monocytes/macrophages

1 reference

12 December 2020

Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte macrophage colony-stimulating factor and interleukin 3.

1 reference

12 December 2020

Cysteinyl leukotriene D4 induced vascular smooth muscle cell proliferation: a possible role in myointimal hyperplasia

1 reference

12 December 2020

BAY x 1005 attenuates atherosclerosis in apoE/LDLR - double knockout mice.

1 reference

12 December 2020

Release of contracting autacoids by aortae of normal and atherosclerotic rabbits

1 reference

12 December 2020

Leukotriene B4production in healthy subjects carrying variants of the arachidonate 5-lipoxygenase-activating protein gene associated with a risk of myocardial infarction

1 reference

12 December 2020

The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor

1 reference

12 December 2020

Monoclonal anti-CD18 antibody prevents transcellular biosynthesis of cysteinyl leukotrienes in vitro and in vivo and protects against leukotriene-dependent increase in coronary vascular resistance and myocardial stiffness.

1 reference

12 December 2020

A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction

1 reference

12 December 2020

5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation

1 reference

12 December 2020

Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment

1 reference

12 December 2020

Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice

1 reference

12 December 2020

Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial

1 reference

12 December 2020

Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils

1 reference

12 December 2020

Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses

1 reference

12 December 2020

Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation

1 reference

12 December 2020

Increased leukotriene concentrations in gingival crevicular fluid from subjects with periodontal disease and atherosclerosis

1 reference

12 December 2020

Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes.

1 reference

12 December 2020

Disruption of TGF-β signaling in T cells accelerates atherosclerosis

1 reference

12 December 2020

Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis

1 reference

12 December 2020

Assessment of in vivo 5-lipoxygenase activity by analysis of leukotriene B4 in saliva: effects of treatment with zileuton

1 reference

12 December 2020

The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke

1 reference

12 December 2020

Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture

1 reference

12 December 2020

Suppression of intimal hyperplasia by a 5-lipoxygenase inhibitor, MK-886: studies with a photochemical model of endothelial injury

1 reference

12 December 2020

Role of cysteinyl leukotrienes in the proliferation and the migration of murine vascular smooth muscle cells in vivo and in vitro

1 reference

12 December 2020

The contractile action of leukotriene B4 in the guinea-pig lung involves a vascular component.

1 reference

12 December 2020

Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease

1 reference

12 December 2020

Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/LDLR-double knockout mice

1 reference

12 December 2020

Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability

1 reference

12 December 2020

The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm.

1 reference

12 December 2020

The oral cavity and age: a site of chronic inflammation?

1 reference

12 December 2020

Association between 5-lipoxygenase expression and plaque instability in humans

1 reference

12 December 2020

The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics

1 reference

12 December 2020

Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice

1 reference

12 December 2020

Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.

1 reference

12 December 2020

Regulation of immune cells by eicosanoid receptors.

1 reference

12 December 2020

Differential leukotriene constrictor responses in human atherosclerotic coronary arteries.

1 reference

12 December 2020

Leukotriene receptors in atherosclerosis

1 reference

12 December 2020

10.1007/S11883-008-0038-7

Identifiers

DOI

1 reference

release_t47voyyasfelhfdossxyvdo3su

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t47voyyasfelhfdossxyvdo3su

24 November 2022

mapped directly with Wikidata item

PubMed ID

18489853

1 reference

PubMed ID

18489853